Prostate Cancer Diagnosis and Treatment
Prostate Cancer Diagnosis and Treatment is a research topic within Pulmonary and Respiratory Medicine. Science Explorer counts 48k research works in it since 1950. 21.4% of them reached the world's top 10% most cited for their field and year.
This cluster of papers encompasses a wide range of research on prostate cancer, including screening methods, treatment options such as radiation therapy and surgery, use of MRI imaging for detection, genetic factors, and clinical guidelines for management. The papers also cover topics like Gleason grading, androgen suppression, biopsy techniques, and long-term survival rates.
- Prostate Cancer
- Screening
- Radiation Therapy
- Gleason Grading
- MRI Imaging
- Androgen Suppression
- Biopsy
- Survival Rates
- Genetic Variants
- Clinical Guidelines
- Research works
- 48k fractional, since 1950
- In the world top 10%
- 10k per year above
- Top-10% rate
- 21.4% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +9% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Prostate Cancer Diagnosis and Treatment research?
By volume, the United States and China publish the most (2.1k and 1k works in 2022–2025).
By volume, 2022–2025
- 1 United States 2.1k works
- 2 China 1k works
- 3 Italy 479 works
- 4 Germany 429 works
- 5 Japan 418 works
- 6 United Kingdom 411 works
- 7 Canada 285 works
- 8 France 269 works
- 9 India 229 works
- 10 Türkiye 227 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Prostate Cancer Diagnosis and Treatment research?
By volume in 2022–2025, Memorial Sloan Kettering Cancer Center publishes the most Prostate Cancer Diagnosis and Treatment research, followed by The University of Texas MD Anderson Cancer Center and University of California, San Francisco.
By volume, 2022–2025
- 1 Memorial Sloan Kettering Cancer CenterUnited States 53 works
- 2 The University of Texas MD Anderson Cancer CenterUnited States 39 works
- 3 University of California, San FranciscoUnited States 37 works
- 4 University of California, Los AngelesUnited States 35 works
- 5 Cleveland ClinicUnited States 33 works
- 6 Istituti di Ricovero e Cura a Carattere ScientificoItaly 31 works
- 7 Johns Hopkins UniversityUnited States 27 works
- 8 Cornell UniversityUnited States 27 works
- 9 University College LondonUnited Kingdom 27 works
- 10 Northwestern UniversityUnited States 27 works
Who are the leading researchers in Prostate Cancer Diagnosis and Treatment?
The most-cited researchers publishing on Prostate Cancer Diagnosis and Treatment include Luigi Ferrucci, Ahmedin Jemal and Richard Kaplan.
- 1 Luigi Ferrucci United States 5.3k citations
- 2 Ahmedin Jemal United States 4.9k citations
- 3 Richard Kaplan United Kingdom 3.4k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Prostate Cancer Diagnosis and Treatment research done?
The largest centres of Prostate Cancer Diagnosis and Treatment research in 2022–2025 are London (United Kingdom), New York (United States), Beijing (China) and Shanghai (China). Among places with at least 20 works in it, it is an unusually large share of all research in Rozzano.
Largest cities, 2022–2025
Where it is the local speciality
- RozzanoIT · 21.5 works18×
Location quotient: how much more of its research is in Prostate Cancer Diagnosis and Treatment than the world average.
Where is the best place to study Prostate Cancer Diagnosis and Treatment?
Among universities, judged by research, Humanitas University, Institute of Cancer Research and Vita-Salute San Raffaele University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Humanitas UniversityItaly | 70.3 | 27.3% | 18.4× | 12 | +207.2% |
| 2 | Institute of Cancer ResearchUnited Kingdom | 68.5 | 33.8% | 53.3× | 14 | +28.8% |
| 3 | Vita-Salute San Raffaele UniversityItaly | 65.2 | 32.0% | 19.9× | 21 | -34.6% |
| 4 | University of California, San FranciscoUnited States | 55.4 | 21.4% | 7.4× | 37 | -15.0% |
| 5 | University College LondonUnited Kingdom | 54.0 | 29.2% | 2.4× | 27 | +75.1% |
| 6 | Karolinska InstitutetSweden | 53.8 | 28.8% | 4.8× | 17 | +11.0% |
| 7 | University of California, Los AngelesUnited States | 53.3 | 24.7% | 4.7× | 35 | +42.0% |
| 8 | Weill Cornell MedicineUnited States | 52.7 | 19.6% | 10.4× | 11 | — |
| 9 | Icahn School of Medicine at Mount SinaiUnited States | 52.6 | 21.2% | 6.0× | 23 | +88.5% |
| 10 | Medical University of ViennaAustria | 51.4 | 25.7% | 6.5× | 16 | +4.9% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Prostate Cancer Diagnosis and Treatment research growing?
Output in 2018–2022 was 9% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Prostate Cancer Diagnosis and Treatment.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.